Shares of Health Care sector company Ionis Pharmaceuticals moved 0.2% today, and are now trading at a price of $40.95. The mid-cap stock's daily volume was 42,122 compared to its average volume of 1,228,391. The S&P 500 index returned a 0.0% performance.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company is based in Carlsbad and has 796 full time employees. Its market capitalization is $5,859,617,280.
19 analysts are following Ionis Pharmaceuticals and have set target prices ranging from $26.0 to $88.0 per share. On average, they have given the company a rating of hold. At today's prices, IONS is trading -15.71% away from its average analyst target price of $48.58 per share.
Over the last year, IONS's share price has increased by 10.3%, which represents a difference of -5.0% when compared to the S&P 500. The stock's 52 week high is $48.82 per share whereas its 52 week low is $32.69. Ionis Pharmaceuticals's average free cash flow over the last 4 years has been $5.68 Million, but they have been decreasing at an average rate of -24.3%. This may prove a challenge to the long term sustainability of the stock's upwards trend.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-31 | -274,370 | -20,099 | -294,469 | -2383.06 |
| 2021-12-31 | 30,799 | -17,901 | 12,898 | 350.16 |
| 2020-12-31 | 35,892 | -41,048 | -5,156 | -101.67 |
| 2019-12-31 | 345,720 | -36,282 | 309,438 | n/a |
